FM regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: R-FM Regimen; Rituximab-Fludarabine-Mitoxantrone Regimen
Overview
FM regimen refers to a regimen consisting of fludarabine and mitoxantrone used for the treatment of indolent non-Hodgkin’s lymphoma.[1]
Regimen
FFludarabine
MMitoxantrone
Indications
References
- ↑ 1.0 1.1 Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A; et al. (2004). “Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma”. J Clin Oncol. 22 (13): 2654–61. doi:10.1200/JCO.2004.07.170. PMID 15159414.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH